AYR Announces Receipt of Senior Noteholder and Court Approval of Previously Announced Plan of Arrangement
MIAMI, Dec. 22, 2023 (GLOBE NEWSWIRE) — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically […]
Stallion Uranium Closes Non-Brokered Private Placement Financing
VANCOUVER, British Columbia, Dec. 22, 2023 (GLOBE NEWSWIRE) — Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; […]
KULR Receives Non-Compliance Notice from NYSE American
Company to Deliver Plan of Compliance to NYSE American SAN DIEGO, Dec. 22, 2023 (GLOBE NEWSWIRE) — KULR Technology Group, […]
Osino Announces Closing of Bridge Private Placement of Common Shares
VANCOUVER, British Columbia, Dec. 22, 2023 (GLOBE NEWSWIRE) — Osino Resources Corp. (TSXV:OSI) (NSX:OSN) (FSE:RSR1) (OTCQX:OSIIF) (“Osino” or the “Company“) […]
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SAN CARLOS, Calif., Dec. 22, 2023 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, […]
FLJ Group Limited Announces Appointment of Directors
SHANGHAI, China, Dec. 22, 2023 (GLOBE NEWSWIRE) — FLJ Group Limited (NASDAQ: FLJ) (the “Company”), today announced that (i) Ms. […]
TSX News -
Goldmoney Inc. Announces Third Property Acquisition in the UK
TORONTO, Dec. 22, 2023 (GLOBE NEWSWIRE) — Goldmoney Inc. (TSX: XAU) (US: XAUMF) (“Goldmoney” or the “Company”), is pleased to […]
Cellectis Reports Results from Shareholders Meeting Held on December 22, 2023
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering […]
Gulf Resources Announces the Receipt of Governmental Notification to Temporarily Close Bromine Facilities
SHOUGUANG, China, Dec. 22, 2023 (GLOBE NEWSWIRE) — Gulf Resources, Inc. (Nasdaq: GURE) (“Gulf Resources” or the “Company”), today announced […]
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
CONSHOHOCKEN, Pa., Dec. 22, 2023 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for […]
